close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

198.17 -4.83 (-2.38%)
Official Closing Price Updated: 6:30 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
PerkinElmer Stock Earns 83 Relative Strength Rating; Buys Lifescience Firm BioLegend
One key metric to look for in a stock is an 80-plus Relative Strength Rating. PerkinElmer stock hit that mark, jumping to 83 on Tuesday. 
Via Investor's Business Daily
Recap: IQVIA Q2 Earnings
Shares of IQVIA Holdings (NYSE:IQV) fell 0.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 80.51% over the past... 
Via Benzinga
IQVIA Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance
From IQVIA Holdings Inc.
Via Business Wire
Earnings Scheduled For July 27, 2021
Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million.... 
Via Benzinga
Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute
From IQVIA
Via Business Wire
Where IQVIA Holdings Stands With Analysts
IQVIA Holdings (NYSE:IQV) has observed the following analyst... 
Via Benzinga
Earnings Outlook For IQVIA Holdings
IQVIA Holdings (NYSE:IQV) announces its next round of earnings this Thursday, April 22. Here is Benzinga's look at IQVIA Holdings's Q1 earnings report. Net Income,... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:... 
Via Benzinga
PerkinElmer Stock Sees Improved Technical Ratings; Still Within Buy Zone
Perkinelmer shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
IQVIA to Announce Second-Quarter 2021 Results on July 27, 2021
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Launches the Clinical Data Analytics Suite (CDAS) to Enable Smarter, Faster Clinical Trials
From IQVIA
Via Business Wire
Q² Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK
From IQVIA
Via Business Wire
Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Patients to Accelerate Adoption of Decentralized Clinical Trials
From IQVIA
Via Business Wire
Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
ASML, Google Lead 5 Stocks That You Can Buy Now
ASML and Google stock, which are on several IBD stock lists, are among several leaders flashing at least early entries. 
Via Investor's Business Daily
IQVIA CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conference on June 2, 2021
From IQVIA
Via Business Wire
Avantor Stock Showing Improved Relative Strength After 350%-Plus Run In Little More Than A Year
In terms of fundamentals, Avantor posted 106% EPS growth last quarter, to 35 cents a share. In the three preceding quarters its EPS grew 19%, 60% and 53%. 
Via Investor's Business Daily
Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes
Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes. 
Via Investor's Business Daily
How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre
The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured... 
Via Benzinga
U.S. District Court Issues Favorable Decision for IQVIA Against Veeva
From IQVIA
Via Business Wire
Charles River Labs Joins Elite List Of Stocks With 95-Plus Composite Rating
Charles River Labs' Accumulation/Distribution Rating of A, on an A+ to E scale, shows heavy buying by institutional investors over the last 13 weeks. 
Via Investor's Business Daily
IQVIA’s Orchestrated Customer Engagement (OCE) Solution Chosen to Support the Commercial Launch of Novel ADHD Drug
From IQVIA
Via Business Wire
Global Medicine Spending to Reach $1.6 Trillion in 2025 Excluding Spending on COVID-19 Vaccines, According to IQVIA Institute for Human Data Science Study
From IQVIA
Via Business Wire
IQVIA Announces Connected Intelligence™
From IQVIA
Via Business Wire
IQVIA Holdings Inc. (IQV) Q1 2021 Earnings Call Transcript
IQV earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
IQVIA Reports First-Quarter Results; Raises Full-Year 2021 Guidance
From IQVIA Holdings Inc.
Via Business Wire
Earnings Scheduled For April 22, 2021
Companies Reporting Before The Bell • Republic First Bancorp (NASDAQ:FRBK) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021
Upgrades According to Argus Research, the prior rating for United Airlines Holdings Inc (NASDAQ:UAL) was changed from Hold to Buy. In the fourth quarter, United Airlines... 
Via Benzinga
Stocks That Hit 52-Week Highs On Tuesday
This morning 106 companies set new 52-week highs. Interesting Highlights: Microsoft (NASDAQ:MSFT) was the largest company by market cap to set a new 52-week high... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today